Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00026
http://purl.obolibrary.org/obo/dinto_DB00026
|
|---|---|
| Preferred Name | anakinra |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | anakinra
|
|---|---|
| label | anakinra
|
| DBSynonym |
icil-1ra
il1 inhibitor
il-1ra
irap
interleukin-1 receptor antagonist protein precursor
il-1rn
See more
See less
|
| ATCCode | L04AC03
|
| Definition | Anakinra is a recombinant, nonglycosylated human interleukin-1 receptor antagonist (IL-1Ra). The difference between anakinra and the native human IL-1Ra is that anakinra has an extra methionine residue at the amino terminus. It is manufactured by using the E. coli expression system. Anakinra is composed of 153 amino acid residues. FDA approved on November 14, 2001.
|
| has pharmacological target | |
| type | |
| blocks | |
| AHFScode | 92:00.00
|
| xref |
Drugs.com:http://www.drugs.com/cdi/anakinra.html
GenBank:M55646
Drugs Product Database (DPD):2245913
National Drug Code Directory:66658-234-28
PharmGKB:PA10799
RxList:http://www.rxlist.com/cgi/generic/anakinra.htm
Wikipedia:http://en.wikipedia.org/wiki/Anakinra
UniProtKB:P18510
See more
See less
|
| CASRN | 143090-92-0
|
| prefixIRI | obo2:dinto_DB00026
|
| may interact with | |
| DBBrand | kineret (amgen inc)
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |